Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
May 14 (Reuters) - Microbot Medical Inc MBOT.O: MICROBOT MEDICAL: RECORDED REVENUE DURING ITS QUARTER ENDED MARCH 31, BENEFITING FROM LIMITED MARKET RELEASE OF LIBERTY SYSTEM MICROBOT MEDICAL INC - Q2 2026 REVENUE TO DATE EXCEEDS Q1 AFTER FULL MARKET RELEASE OF LIBERTY SYSTEM Source text: ID:nGNX87HJX2 Further company coverage: MBOT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones